FITC Anti-Human CD29 Antibody[TS2/16.2.1]

FITC Anti-Human CD29 Antibody[TS2/16.2.1]

The FITC Anti-Human CD29 Antibody[TS2/16.2.1] is a monoclonal antibody that is designed to target the CD29 antigen, which is also known as integrin beta-1. This antibody is conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of the target antigen. The antibody has been extensively tested and validated for use in flow cytometry, immunohistochemistry, and immunofluorescence applications.

CD29 is a transmembrane glycoprotein that is expressed on the surface of various cell types, including leukocytes, endothelial cells, and fibroblasts. It plays a crucial role in cell adhesion, migration, and signaling, and is involved in a wide range of physiological and pathological processes, such as inflammation, wound healing, angiogenesis, and cancer metastasis. The FITC Anti-Human CD29 Antibody[TS2/16.2.1] specifically recognizes the extracellular domain of CD29 and can be used to study its expression and function in different cell types and tissues.

The FITC Anti-Human CD29 Antibody[TS2/16.2.1] is a high-quality research tool that offers excellent sensitivity, specificity, and reproducibility. It is supplied as a liquid in phosphate-buffered saline (PBS) with 0.1% sodium azide as a preservative. The antibody is available in different sizes and formats to meet the needs of various experimental setups and applications. It is recommended to optimize the staining conditions and use appropriate controls to ensure accurate and reliable results. Overall, the FITC Anti-Human CD29 Antibody[TS2/16.2.1] is a valuable reagent for investigating the role of CD29 in normal and pathological processes and for developing new diagnostic and therapeutic strategies.